Volume 27, Number 4—April 2021
Research
COVID-19–Associated Pulmonary Aspergillosis, March–August 2020
Table 3
Country, site no. | CAPA cases, no. | Denominator, no. (% CAPA) |
Timeframe | ||
---|---|---|---|---|---|
COVID-19 patients | COVID-19 patients in ICU | COVID-19 patients on mechanical ventilation | |||
Argentina, I | 2 | 673 (0.3) | 163 (1.2) | 69 (2.9) | Mar–Aug |
Belgium, I | 4 | 274 (1.5) | 46 (8.7) | 32 (12.5) | Mar–Aug |
Belgium, II | 4 | NA | 34 (11.8) | 20 (20.0) | Mar–Apr |
France, I | 2 | 519 (0.4) | 113 (1.8) | 45 (4.4) | Mar–Aug |
Germany, I | 1 | 83 (1.2) | 18 (5.6) | 15 (6.7) | Mar–Aug |
Germany, II | 11 | 231 (4.8) | 64 (17.2) | 56 (19.6) | Mar–Aug |
Germany, III | 9 | 93 (9.7) | 38 (23.7) | 27 (33.3) | Mar–Aug |
Germany, IV | 7 | 123 (5.7) | 76 (9.2) | 57 (12.3) | Mar–Aug |
Ireland, I | 3 | 181 (1.7) | 15 (20.0) | 14 (21.4) | Mar–Aug |
Italy, I | 2 | 1,279 (0.2) | 196 (1.0) | 188 (1.1) | Mar–Aug |
Italy, II | 8 | 1,055 (0.8) | 144 (5.6) | 142 (5.6) | Mar–Aug |
Mexico, I | 6 | 312 (1.9) | 131 (4.6) | 115 (5.2) | Mar–Aug |
Netherlands, I | 9 | NA | NA | 53 (17.0) | Apr |
Netherlands, II | 6 | 483 (1.2) | 118 (5.1) | NA | Mar–Aug |
Pakistan, I | 9 | 147 (6.1) | 23 (39.1) | 19 (47.4) | Mar–Apr |
Spain, I | 8 | 1,543 (0.5) | 348 (2.3) | 146 (5.5) | Mar–Aug |
Spain, II | 8 | 7,880 (0.1) | NA | NA | Mar–Aug |
Spain, III | 10 | 5,890 (0.2) | NA | NA | Mar–Aug |
Switzerland, I | 3 | NA | 118 (2.5) | 80 (3.8) | Mar–May |
United Kingdom, I | 19 | 14,615 (0.1) | 257 (7.4) | 200 (9.5) | Mar–May |
Total | 131 | 35,381 (0.4) | 1,902 (6.9) | 1,278 (10.3) | Mar–Aug |
*CAPA, COVID-19–associated pulmonary aspergillosis; COVID-19, coronavirus disease; ICU, intensive care unit; NA, not available.
1These senior authors contributed equally to this article.
2Members of this group are listed at the end of this article.
Page created: February 02, 2021
Page updated: March 18, 2021
Page reviewed: March 18, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.